{
  "id": 34,
  "university": "PCI",
  "regulation": "Master",
  "course": "B.Pharm",
  "effective_year": null,
  "curriculum_type": "pci",
  "curriculum_data": {
    "years": [
      {
        "year": 4,
        "semesters": [
          {
            "semester": 7,
            "subjects": [
              {
                "code": "BP702T",
                "name": "Industrial Pharmacy II",
                "type": "theory",
                "category": "core",
                "units": [
                  {
                    "number": "Unit I",
                    "title": "Pilot Plant Scale Up Techniques",
                    "topics": [
                      "General considerations for pilot plant scale up",
                      "Significance of personnel requirements",
                      "Significance of space requirements",
                      "Significance of raw materials",
                      "Pilot plant scale up considerations for solids",
                      "Pilot plant scale up considerations for liquid orals",
                      "Pilot plant scale up considerations for semi solids",
                      "Documentation for pilot plant scale up",
                      "SUPAC guidelines",
                      "Introduction to platform technology"
                    ]
                  },
                  {
                    "number": "Unit II",
                    "title": "Technology Development and Transfer",
                    "topics": [
                      "WHO guidelines for Technology Transfer (TT)",
                      "Terminology of Technology Transfer",
                      "Technology transfer protocol",
                      "Quality risk management",
                      "Transfer from R & D to production (Process)",
                      "Transfer from R & D to production (Packaging)",
                      "Transfer from R & D to production (Cleaning)",
                      "Granularity of TT Process for API",
                      "Granularity of TT Process for excipients",
                      "Granularity of TT Process for finished products",
                      "Granularity of TT Process for packaging materials",
                      "Documentation for Technology Transfer",
                      "Premises and equipments for Technology Transfer",
                      "Qualification and validation in Technology Transfer",
                      "Quality control in Technology Transfer",
                      "Analytical method transfer",
                      "Approved regulatory bodies and agencies",
                      "Commercialization practical aspects",
                      "Commercialization problems (case studies)",
                      "TT agencies in India - APCTD",
                      "TT agencies in India - NRDC",
                      "TT agencies in India - TIFAC",
                      "TT agencies in India - BCIL",
                      "TT agencies in India - TBSE / SIDBI",
                      "TT related documentation - confidentiality agreement",
                      "TT related documentation - licensing",
                      "TT related documentation - MoUs",
                      "Legal issues in Technology Transfer"
                    ]
                  },
                  {
                    "number": "Unit III",
                    "title": "Regulatory Affairs",
                    "topics": [
                      "Introduction to Regulatory Affairs",
                      "Historical overview of Regulatory Affairs",
                      "Regulatory authorities",
                      "Role of Regulatory affairs department",
                      "Responsibility of Regulatory Affairs Professionals",
                      "Drug Development Teams",
                      "Non-Clinical Drug Development",
                      "Pharmacology in drug approval",
                      "Drug Metabolism in drug approval",
                      "Toxicology in drug approval",
                      "General considerations of Investigational New Drug (IND) Application",
                      "Investigatorâ€™s Brochure (IB)",
                      "New Drug Application (NDA)",
                      "Clinical research",
                      "BE studies",
                      "Clinical Research Protocols",
                      "Biostatistics in Pharmaceutical Product Development",
                      "Data Presentation for FDA Submissions",
                      "Management of Clinical Studies"
                    ]
                  },
                  {
                    "number": "Unit IV",
                    "title": "Quality Management Systems",
                    "topics": [
                      "Quality management & Certifications",
                      "Concept of Quality",
                      "Total Quality Management",
                      "Quality by Design (QbD)",
                      "Six Sigma concept",
                      "Out of Specifications (OOS)",
                      "Change control",
                      "Introduction to ISO 9000 series of quality systems standards",
                      "ISO 14000",
                      "NABL",
                      "GLP"
                    ]
                  },
                  {
                    "number": "Unit V",
                    "title": "Indian Regulatory Requirements",
                    "topics": [
                      "Central Drug Standard Control Organization (CDSCO)",
                      "State Licensing Authority",
                      "Organization of CDSCO",
                      "Responsibilities of CDSCO",
                      "Organization of State Licensing Authority",
                      "Responsibilities of State Licensing Authority",
                      "Certificate of Pharmaceutical Product (COPP)",
                      "Regulatory requirements for New Drugs",
                      "Approval procedures for New Drugs"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "university": "Generic University",
    "regulation": "PCI Regulation",
    "course": "B.Pharm"
  },
  "stats": {
    "years": 4,
    "semesters": 7,
    "subjects": 1,
    "units": 5,
    "topics": 77,
    "theory": 1,
    "practical": 0,
    "electives": 0
  },
  "status": "active",
  "created_at": "2025-12-16T07:35:52.558582+00:00",
  "updated_at": null
}